Doccla Secures $3.3M Seed Funding for Virtual Wards Platform

Doccla Secures $3.3 Million Seed Funding for Remote Patient Monitoring

Doccla, a health tech startup focused on patient monitoring both within hospital settings and at home, has successfully closed a $3.3 million seed funding round. This investment was spearheaded by Giant Ventures and Speedinvest.

Addressing Healthcare Bottlenecks

The company’s platform is designed to help hospitals anticipate bed availability by remotely monitoring patients utilizing wearable medical devices. This capability directly addresses and helps to alleviate existing bottlenecks within the healthcare system.

Proven Impact on the NHS

Founded by Martin Ratz, a health entrepreneur, and Dag Larrson, a tech entrepreneur, Doccla reports significant positive outcomes. They state their technology has contributed to “thousands of bed days” saved for the NHS.

Specifically, the company claims a 29% decrease in Emergency Admissions and a 20% reduction in attendance at A&E departments.

Competitive Landscape

Doccla operates within a growing market alongside competitors such as Current Health, Huma, and Cadence. Cadence recently secured $41 million in funding from Thrive and General Catalyst.

These platforms generally focus on remote patient monitoring, enabling clinicians to track patient health at home and deliver personalized guidance through text messages and video consultations. Doccla also provides at-home patient measurement capabilities.

Future Expansion and Technology Investment

The newly acquired funding will be strategically allocated to enhance Doccla’s technology. This includes deeper integration with medical wearables and electronic health record systems.

Furthermore, the company intends to extend its reach into additional European healthcare markets.

The Pandemic's Influence

Like many similar technologies, Doccla’s development was significantly accelerated by the pressures of the COVID-19 pandemic. Overwhelmed hospitals quickly recognized the need for solutions like virtual wards.

These virtual wards allowed for continuous patient monitoring, both during hospital stays and following discharge.

CEO's Perspective

Dag Larsson, CEO and co-founder of Doccla, stated, “Our end-to-end virtual ward services are extremely easy for the care provider to take on and extremely hard for them to ignore.”

He further emphasized, “The NHS now faces a challenging winter season and we’re evolving our technology to support care providers.”

Larsson highlighted a key differentiator: “We differ a lot from the competition in that we support the entire patient journey (e.g. all last-mile activities like logistics, customer service, and even pre-configured mobile phones). This has made us punch substantially over our weight and win contracts with extremely high patient and clinician approval.”

Investor Insights

Cameron McLain, managing partner and co-founder from Giant Ventures, commented: “Doccla provides a vital solution for a strained healthcare system, delivering a product that improves the patient experience and tackles cost.”

Felix Faltin, principal and Digital Health lead at Speedinvest, added, “Doccla’s platform is more than a product, it’s a full-stack solution that makes care delivery more efficient for providers, cheaper for payors and safer for patients, long past COVID-19.”